Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OPLAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EXOSC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPAA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHARPIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRINA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on